SPG 302
Alternative Names: SPG-302Latest Information Update: 14 Aug 2024
At a glance
- Originator Spinogenix
- Developer Novotech; Spinogenix
- Class Antidementias; Benzene derivatives; Benzothiazoles; Ethylene glycols; Neuroprotectants; Small molecules
- Mechanism of Action Synaptic transmission modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alzheimer's disease; Schizophrenia
- Phase I/II Amyotrophic lateral sclerosis